Brand Name | Status | Last Update |
---|---|---|
detectnet | New Drug Application | 2025-01-31 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 2 | 2 | 2 | 1 | 3 | 10 |
Neoplasms | D009369 | — | C80 | 1 | — | — | 1 | 1 | 3 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | 1 | 1 | 2 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | 1 | 1 | 2 |
Intestinal neoplasms | D007414 | — | C26.0 | — | — | — | 1 | 1 | 2 |
Islet cell adenoma | D007516 | EFO_0007331 | D13.7 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pheochromocytoma | D010673 | — | — | — | 1 | — | — | 1 | 2 |
Paraganglioma | D010235 | — | — | — | 1 | — | — | 1 | 2 |
Neuroendocrine carcinoma | D018278 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcoidosis | D012507 | EFO_0000690 | D80-D89 | — | — | — | — | 2 | 2 |
Gastrointestinal neoplasms | D005770 | — | C26.9 | — | — | — | — | 1 | 1 |
Digestive system neoplasms | D004067 | — | — | — | — | — | — | 1 | 1 |
Gastrointestinal diseases | D005767 | — | — | — | — | — | — | 1 | 1 |
Germ cell and embryonal neoplasms | D009373 | — | — | — | — | — | — | 1 | 1 |
Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | — | — | — | — | 1 | 1 |
Neoplasms by histologic type | D009370 | — | — | — | — | — | — | 1 | 1 |
Endocrine gland neoplasms | D004701 | EFO_0003769 | D35 | — | — | — | — | 1 | 1 |
Neoplasms by site | D009371 | — | — | — | — | — | — | 1 | 1 |
Nerve tissue neoplasms | D009380 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Copper oxodotreotide cu-64 |
INN | _ |
Description | Copper oxodotreotide cu-64 is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | peptides: inhibition of growth hormone release |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4297339 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | N3858377KC (ChemIDplus, GSRS) |